KBC Group’s Guardant Health GH Stock Holding History

KBC Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$670K	Sell	3,757 -5,163	-58%	-$844K	﹤0.01%	753
2026 Q2	$1.34M	Buy	8,920 +1,383	+18%	+$150K	﹤0.01%	715
2026 Q1	$696K	Buy	7,537 +4,403	+140%	+$442K	﹤0.01%	757
2025 Q4	$320K	Hold	3,134	–	–	﹤0.01%	782
2025 Q3	$196K	Hold	3,134	–	–	﹤0.01%	911
2025 Q2	$163K	Sell	3,134 -2,503	-44%	-$112K	﹤0.01%	947
2025 Q1	$240K	Sell	5,637 -21	-0.4%	-$906	﹤0.01%	970
2024 Q4	$173K	Buy	5,658 +2,200	+64%	+$61.9K	﹤0.01%	1211
2024 Q3	$79K	Hold	3,458	–	–	﹤0.01%	1443
2024 Q2	$100K	Hold	3,458	–	–	﹤0.01%	1160
2024 Q1	$71K	Buy	3,458 +1,080	+45%	+$23.2K	﹤0.01%	1323
2023 Q4	$64K	Hold	2,378	–	–	﹤0.01%	1349
2023 Q3	$70K	Buy	+2,378	New	+$83.6K	﹤0.01%	1188

Other funds holding GH

AGF Management Toronto, Ontario, Canada $24.5B AUM 50.2% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Sicart Associates New York $413M AUM 28.3% 1-Year Est. Return

Vestor Capital Chicago, Illinois $1.62B AUM 34.01% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

KBC Group's GH Position: Q3 2026 in Review

KBC Group reduced its Guardant Health (GH) stake by 58% in Q3 2026, selling an estimated $844K and leaving 3,757 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #753.

KBC Group first reported a position in GH in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.34M in Q2 2026. 225 funds tracked by Wall St. Rank hold GH as of Q3 2026.

KBC Group held 3,757 shares of Guardant Health worth $670K as of Q3 2026.
KBC Group sold 5,163 Guardant Health shares in Q3 2026, an estimated $844K.
Guardant Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #753 holding.
KBC Group first reported a position in Guardant Health in Q3 2023 and has held it in 13 quarters since.
KBC Group's Guardant Health position peaked at $1.34M in Q2 2026.
225 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.